Bruce E. Dornseif

1.4k total citations
23 papers, 1.1k citations indexed

About

Bruce E. Dornseif is a scholar working on Pharmacology, Clinical Psychology and Economics and Econometrics. According to data from OpenAlex, Bruce E. Dornseif has authored 23 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pharmacology, 4 papers in Clinical Psychology and 4 papers in Economics and Econometrics. Recurrent topics in Bruce E. Dornseif's work include Treatment of Major Depression (7 papers), Statistical Methods in Clinical Trials (4 papers) and Health Systems, Economic Evaluations, Quality of Life (3 papers). Bruce E. Dornseif is often cited by papers focused on Treatment of Major Depression (7 papers), Statistical Methods in Clinical Trials (4 papers) and Health Systems, Economic Evaluations, Quality of Life (3 papers). Bruce E. Dornseif collaborates with scholars based in United States and Switzerland. Bruce E. Dornseif's co-authors include Charles M. Beasley, J C Bosomworth, Alvin H. Rampey, Daniel N. Masica, Mary E. Sayler, Parke A. Rublee, Denis Murphy, Janet H. Potvin, Roger B. Hanson and Ralph T. Doyle and has published in prestigious journals such as Circulation, Limnology and Oceanography and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Bruce E. Dornseif

22 papers receiving 987 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bruce E. Dornseif United States 15 539 261 186 177 128 23 1.1k
James C. Garriott United States 26 323 0.6× 71 0.3× 24 0.1× 105 0.6× 67 0.5× 73 1.7k
Marc B. Stone United States 8 198 0.4× 185 0.7× 77 0.4× 249 1.4× 34 0.3× 14 624
J.A. Henry United Kingdom 15 476 0.9× 214 0.8× 74 0.4× 286 1.6× 153 1.2× 40 1.4k
Ajay K. Parsaik United States 23 89 0.2× 224 0.9× 65 0.3× 75 0.4× 382 3.0× 46 1.8k
Ruth Landau United States 25 225 0.4× 70 0.3× 25 0.1× 46 0.3× 217 1.7× 57 2.0k
Jens Bohlken Germany 19 132 0.2× 441 1.7× 32 0.2× 235 1.3× 66 0.5× 106 1.5k
Glen L. Stimmel United States 20 252 0.5× 572 2.2× 78 0.4× 145 0.8× 59 0.5× 44 1.2k
Angela DeVeaugh‐Geiss United States 14 359 0.7× 250 1.0× 168 0.9× 59 0.3× 55 0.4× 33 860
Hye Youn Park South Korea 17 43 0.1× 154 0.6× 142 0.8× 249 1.4× 40 0.3× 58 973
Mark B. Mycyk United States 18 176 0.3× 98 0.4× 17 0.1× 91 0.5× 18 0.1× 64 713

Countries citing papers authored by Bruce E. Dornseif

Since Specialization
Citations

This map shows the geographic impact of Bruce E. Dornseif's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bruce E. Dornseif with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bruce E. Dornseif more than expected).

Fields of papers citing papers by Bruce E. Dornseif

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bruce E. Dornseif. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bruce E. Dornseif. The network helps show where Bruce E. Dornseif may publish in the future.

Co-authorship network of co-authors of Bruce E. Dornseif

This figure shows the co-authorship network connecting the top 25 collaborators of Bruce E. Dornseif. A scholar is included among the top collaborators of Bruce E. Dornseif based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bruce E. Dornseif. Bruce E. Dornseif is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Luo, Xiaolong, Mingyu Li, Chengqing Wu, et al.. (2015). A proposed approach for analyzing post-study therapy effect in survival analysis. Journal of Biopharmaceutical Statistics. 26(4). 790–800. 2 indexed citations
2.
Wang, Jianming, Chunlei Ke, Zhinuan Yu, Lei Fu, & Bruce E. Dornseif. (2015). Predicting analysis time in events‐driven clinical trials using accumulating time‐to‐event surrogate information. Pharmaceutical Statistics. 15(3). 198–207. 1 indexed citations
3.
Dornseif, Bruce E., et al.. (2014). 80-7 Fate and effects of oil on Georgia coastal waters and marshes.
4.
Mendell, Jeanne, Helen Kastrissios, Michelle Green, et al.. (2012). Modelling and simulation of edoxaban exposure and response relationships in patients with atrial fibrillation. Thrombosis and Haemostasis. 107(5). 925–934. 107 indexed citations
5.
Palangio, Mark, Donald W. Northfelt, Russell K. Portenoy, et al.. (2002). Dose Conversion and Titration with a Novel, Once-Daily, OROS® Osmotic Technology, Extended-Release Hydromorphone Formulation in the Treatment of Chronic Malignant or Nonmalignant Pain. Journal of Pain and Symptom Management. 23(5). 355–368. 64 indexed citations
6.
7.
Preston, Sandra L., George L. Drusano, Cynthia L. Fowler, et al.. (1998). Levofloxacin Population Pharmacokinetics and Creation of a Demographic Model for Prediction of Individual Drug Clearance in Patients with Serious Community-Acquired Infection. Antimicrobial Agents and Chemotherapy. 42(5). 1098–1104. 97 indexed citations
8.
Goldstein, D., et al.. (1993). Fluoxetine: A Randomized Clinical Trial in the Maintenance of Weight Loss. Obesity Research. 1(2). 92–98. 32 indexed citations
9.
Beasley, Charles M., Janet H. Potvin, Daniel N. Masica, et al.. (1992). Fluoxetine: no association with suicidality in obsessive-compulsive disorder. Journal of Affective Disorders. 24(1). 1–10. 30 indexed citations
10.
Heiligenstein, John H., Emil F. Coccaro, Janet H. Potvin, et al.. (1992). Fluoxetine Not Associated With Increased Violence or Aggression in Controlled Clinical Trials. Annals of Clinical Psychiatry. 4(4). 285–295. 7 indexed citations
11.
Beasley, Charles M., Bruce E. Dornseif, J C Bosomworth, et al.. (1992). Fluoxetine and Suicide. International Clinical Psychopharmacology. 6. 35–57. 9 indexed citations
12.
Beasley, Charles M., et al.. (1991). Fluoxetine versus trazodone: efficacy and activating-sedating effects.. PubMed. 52(7). 294–9. 73 indexed citations
13.
Dornseif, Bruce E., et al.. (1990). Pattern analysis shows beneficial effect of fluoxetine treatment in mild depression.. PubMed. 26(2). 173–80. 54 indexed citations
14.
Carter, Walter H. & Bruce E. Dornseif. (1990). Maximizing Drug Benefit in Combination Therapy (Dose-Response Estimation). Drug Information Journal. 24(2). 351–359. 4 indexed citations
15.
Enas, Gregory G., et al.. (1989). Monitoring versus interim analysis of clinical trials: A perspective from the pharmaceutical industry. Controlled Clinical Trials. 10(1). 57–70. 21 indexed citations
16.
Goldberg, Michael R., Frank W. Rockhold, Walter Offen, & Bruce E. Dornseif. (1989). Dose-effect and concentration-effect relationships of pinacidil and hydrochlorothiazide in hypertension. Clinical Pharmacology & Therapeutics. 46(2). 208–218. 13 indexed citations
17.
Brown, W. A., et al.. (1988). Placedo response in depression: A search for predictors. Psychiatry Research. 26(3). 259–264. 37 indexed citations
18.
Wernicke, J. F., et al.. (1988). Low-dose fluoxetine therapy for depression.. PubMed. 24(1). 183–8. 82 indexed citations
19.
Dornseif, Bruce E., et al.. (1981). Fate and effects of a heavy fuel oil spill on a Georgia salt marsh. Marine Environmental Research. 5(2). 125–143. 24 indexed citations
20.
Rublee, Parke A. & Bruce E. Dornseif. (1978). Direct Counts of Bacteria in the Sediments of a North Carolina Salt Marsh. Estuaries. 1(3). 188–188. 57 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026